[go: up one dir, main page]

ZA200900706B - Fused ring spiroketal derivative and use thereof as anti-diabetic drug - Google Patents

Fused ring spiroketal derivative and use thereof as anti-diabetic drug

Info

Publication number
ZA200900706B
ZA200900706B ZA200900706A ZA200900706A ZA200900706B ZA 200900706 B ZA200900706 B ZA 200900706B ZA 200900706 A ZA200900706 A ZA 200900706A ZA 200900706 A ZA200900706 A ZA 200900706A ZA 200900706 B ZA200900706 B ZA 200900706B
Authority
ZA
South Africa
Prior art keywords
fused ring
diabetic drug
spiroketal derivative
ring spiroketal
derivative
Prior art date
Application number
ZA200900706A
Other languages
English (en)
Inventor
Tsutomu Sato
Yoshihito Ohtake
Masahiro Nishimoto
Takashi Emura
Takamitsu Kobayashi
Marina Yamaguchi
Kyouko Takami
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38981587&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200900706(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ZA200900706B publication Critical patent/ZA200900706B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
ZA200900706A 2006-07-27 2007-07-27 Fused ring spiroketal derivative and use thereof as anti-diabetic drug ZA200900706B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006205242 2006-07-27

Publications (1)

Publication Number Publication Date
ZA200900706B true ZA200900706B (en) 2010-05-26

Family

ID=38981587

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900706A ZA200900706B (en) 2006-07-27 2007-07-27 Fused ring spiroketal derivative and use thereof as anti-diabetic drug

Country Status (18)

Country Link
US (1) US8207134B2 (xx)
EP (1) EP2048152A4 (xx)
JP (1) JP5165565B2 (xx)
KR (1) KR20090033911A (xx)
CN (1) CN101495494A (xx)
AR (1) AR062110A1 (xx)
AU (1) AU2007277704A1 (xx)
BR (1) BRPI0715248A2 (xx)
CA (1) CA2658921A1 (xx)
CL (1) CL2007002186A1 (xx)
IL (1) IL196585A0 (xx)
MX (1) MX2009000579A (xx)
NO (1) NO20090173L (xx)
PE (1) PE20080521A1 (xx)
RU (1) RU2009106866A (xx)
TW (1) TWI432446B (xx)
WO (1) WO2008013277A1 (xx)
ZA (1) ZA200900706B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4260770B2 (ja) 2005-05-09 2009-04-30 任天堂株式会社 ゲームプログラムおよびゲーム装置
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP4825322B1 (ja) 2008-08-28 2011-11-30 ファイザー・インク ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
NZ599945A (en) 2009-11-02 2014-05-30 Pfizer Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2011070592A2 (en) 2009-12-09 2011-06-16 Panacea Biotec Ltd. Novel sugar derivatives
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
ITMI20110362A1 (it) * 2011-03-09 2012-09-10 F I S Fabbrica Italiana Sint P A Procedimento per la preparazione di 1-(6-metilpiridin-3-il)-2-[4-(metilsolfonil)fenil]etanone, un intermedio dell'etoricoxib.
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2755722B1 (en) 2011-09-13 2017-05-24 Panacea Biotec Ltd. Novel sglt inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN105001174A (zh) * 2015-07-14 2015-10-28 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途
CN104987314A (zh) * 2015-07-14 2015-10-21 佛山市赛维斯医药科技有限公司 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途
CN110483475B (zh) * 2019-08-15 2020-11-27 绍兴文理学院 一种氧化银催化法制备苯并噻吩类化合物的方法
CN110483476B (zh) * 2019-08-15 2020-11-27 绍兴文理学院 一种催化法制备苯并硒吩类化合物的工艺
CN112574226A (zh) * 2020-12-15 2021-03-30 海门华祥医药科技有限公司 5,6-亚甲基二氧基吲哚的制备方法
CN116178143B (zh) * 2021-11-26 2024-10-01 中国科学院大连化学物理研究所 一种1,4-萘二甲酸/酯、1,4-萘二甲酸衍生物及其制备方法和应用
CN117050126A (zh) * 2023-08-15 2023-11-14 南京华威医药科技集团有限公司 一种新的托格列净关键异构体制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470845A (en) 1992-10-28 1995-11-28 Bristol-Myers Squibb Company Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
US5760246A (en) 1996-12-17 1998-06-02 Biller; Scott A. Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
JP2000080041A (ja) 1998-03-09 2000-03-21 Tanabe Seiyaku Co Ltd 医薬組成物
US6515117B2 (en) 1999-10-12 2003-02-04 Bristol-Myers Squibb Company C-aryl glucoside SGLT2 inhibitors and method
PH12000002657B1 (en) 1999-10-12 2006-02-21 Bristol Myers Squibb Co C-aryl glucoside SGLT2 inhibitors
US6627611B2 (en) 2000-02-02 2003-09-30 Kotobuki Pharmaceutical Co Ltd C-glycosides and preparation of thereof as antidiabetic agents
CZ20023023A3 (cs) 2000-03-17 2003-04-16 Kissei Pharmaceutical Co., Ltd. Glukopyranosyloxybenzylbenzenové deriváty, léčivé směsi obsahující tyto látky a meziprodukty pro přípravu derivátů
ES2258141T3 (es) 2001-04-11 2006-08-16 Bristol-Myers Squibb Company Complejos de aminoacidos de glucosidos c-arilo para el tratamiento de la diabetes y procedimiento.
DE10231370B4 (de) 2002-07-11 2006-04-06 Sanofi-Aventis Deutschland Gmbh Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
TWI254635B (en) 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
PT1980560E (pt) 2003-03-14 2011-06-29 Astellas Pharma Inc Derivados de c-glicósido para o tratamento da diabetes
WO2005011592A2 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted indazole-o-glucosides
CA2549015A1 (en) * 2003-08-01 2005-02-10 Janssen Pharmaceutica N.V. Substituted fused heterocyclic c-glycosides
KR100942622B1 (ko) * 2003-08-01 2010-02-17 미쓰비시 타나베 파마 코퍼레이션 나트륨-의존성 수송체에 대해 저해 활성을 갖는 신규화합물
TW200526678A (en) * 2003-08-01 2005-08-16 Janssen Pharmaceutica Nv Substituted indole-O-glucosides
TW200524951A (en) * 2003-08-01 2005-08-01 Janssen Pharmaceutica Nv Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
JP4950657B2 (ja) 2004-03-04 2012-06-13 キッセイ薬品工業株式会社 縮合複素環誘導体、それを含有する医薬組成物およびその医薬用途
US7732596B2 (en) 2004-03-04 2010-06-08 Kissei Pharmaceutical Co., Ltd. Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
NZ550464A (en) 2004-03-16 2010-10-29 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
US7393836B2 (en) 2004-07-06 2008-07-01 Boehringer Ingelheim International Gmbh D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
DE102004034690A1 (de) 2004-07-17 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
WO2006010557A1 (de) 2004-07-27 2006-02-02 Boehringer Ingelheim International Gmbh D-glucopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
WO2006018150A1 (de) 2004-08-11 2006-02-23 Boehringer Ingelheim International Gmbh D-xylopyranosyl-phenyl-substituierte cyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung
AR051446A1 (es) 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
DE102004048388A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg D-Pyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
CA2588963C (en) * 2004-11-18 2013-06-25 Kissei Pharmaceutical Co., Ltd. 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
TW200637869A (en) 2005-01-28 2006-11-01 Chugai Pharmaceutical Co Ltd The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
WO2007140191A2 (en) * 2006-05-23 2007-12-06 Theracos, Inc. Glucose transport inhibitors and methods of use
US7795228B2 (en) * 2006-12-28 2010-09-14 Theracos, Inc. Spiroheterocyclic glycosides and methods of use

Also Published As

Publication number Publication date
NO20090173L (no) 2009-04-27
RU2009106866A (ru) 2010-09-10
JPWO2008013277A1 (ja) 2009-12-17
TWI432446B (zh) 2014-04-01
CL2007002186A1 (es) 2008-02-01
US20100234609A1 (en) 2010-09-16
EP2048152A1 (en) 2009-04-15
IL196585A0 (en) 2009-11-18
WO2008013277A1 (fr) 2008-01-31
CN101495494A (zh) 2009-07-29
CA2658921A1 (en) 2008-01-31
MX2009000579A (es) 2009-01-27
TW200821323A (en) 2008-05-16
AR062110A1 (es) 2008-10-15
JP5165565B2 (ja) 2013-03-21
PE20080521A1 (es) 2008-06-13
AU2007277704A1 (en) 2008-01-31
KR20090033911A (ko) 2009-04-06
EP2048152A4 (en) 2013-01-23
BRPI0715248A2 (pt) 2013-06-04
US8207134B2 (en) 2012-06-26

Similar Documents

Publication Publication Date Title
ZA200900706B (en) Fused ring spiroketal derivative and use thereof as anti-diabetic drug
IL196799A0 (en) Fused heterocyclic derivative and use thereof
IL196586A0 (en) Substituted spiroketal derivatives and use thereof as therapeutic drug for diabetes
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
PL2005958T3 (pl) Kompozycja farmaceutyczna do stosowania zewnętrznego
EP2157093A4 (en) HETEROCYCLIC PYRROLO-NITROGEN-DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL USE
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
IL192826A0 (en) Thiazole derivatives, their preparation and pharmaceutical compositions containing them
HK1126760A1 (en) Novel pyrone-indole derivatives and process for their preparation
IL196228A0 (en) 4-hydroxythiobenzamide derivatives of drugs
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
HK1130049A1 (en) Tricyclic compound and pharmaceutical use thereof
ZA200900230B (en) 4-hydroxythiobenzamide derivatives of drugs
IL192700A0 (en) Use of elderberry extract
EP2145889A4 (en) HETEROCYCLIC FUSED CORE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE DERIVATIVE, AND USE OF THE COMPOSITION FOR MEDICAL PURPOSES
EP2147922A4 (en) CONDENSED HETEROCYCLIC DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE, AND USE OF THE COMPOSITION FOR MEDICAL PURPOSES
SI2220047T1 (sl) Derivati kinolina, farmacevtski sestavki, ki jih vsebujejo in njihova uporaba
IL191892A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
PL1934388T3 (pl) Sposób projektowania leków
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof
EP2204173A4 (en) PHARMACEUTICAL COMPOSITION HAVING ANTIDIABETIC EFFECT
ZA200808225B (en) Substituted prolinamides, production thereof and their use as drugs
GB0622332D0 (en) Drug